Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June Jun 6, 2018 05:01AM
Calithera Biosciences (CALA) PT Lowered to $12 at JMP Securities Apr 9, 2018 01:49AM
Calithera Biosciences to Participate in the JMP Securities 2017 Life Sciences Conference Jun 14, 2017 07:00AM
Calithera Biosciences (CALA) PT Raised to $17 at JMP Securities Following Recent Developments with CB-839 & CB-1158 Mar 29, 2017 08:25AM
JMP Securities Reiterates Market Outperform Rating and $12 PT on Calithera Biosciences (CALA) Following Achievement of PK & PD Goals in Ph1 Trial of CB-1158 Mar 28, 2017 11:14AM


Mar 27, 2017 04:04PM Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares
Mar 22, 2017 07:14AM Calithera Biosciences (CALA) Prices 6.83M Common Stock Offering at $10.25/Share
Mar 22, 2017 07:00AM Calithera Biosciences, Inc. Prices Public Offering of 6,830,000 shares of Common Stock
Mar 20, 2017 04:02PM Calithera Biosciences (CALA) to Offer 4.5M Shares of Common Stock
Mar 20, 2017 04:02PM Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock
Jan 30, 2017 12:19PM Incyte Deal Further Validates Calithera Biosciences (CALA) Program - JMP
Jun 23, 2015 07:02AM Calithera Biosciences (CALA) Selects CB-1158 as Immuno-Oncology Clinical Candidate
Jun 23, 2015 07:00AM Calithera Biosciences Selects Immuno-Oncology Clinical Candidate CB-1158, an Oral Arginase Inhibitor for the Treatment of Cancer
Jun 23, 2015 07:00AM Calithera Biosciences Selects Immuno-Oncology Clinical Candidate CB-1158, an Oral Arginase Inhibitor for the Treatment of Cancer
Jun 16, 2015 09:00AM Calithera Biosciences to Present at the JMP Securities Life Sciences Conference 2015
Oct 2, 2014 10:39AM Calithera Biosciences (CALA) IPO Opens Modesty Higher